Loading clinical trials...
Loading clinical trials...
Assessing Immunological Basis of Durable Antibody Responses to 9-valent HPV Vaccination
Conditions
Interventions
Gardasil-9
Lidocaine injections
Locations
2
United States
The Hope Clinic of Emory University
Atlanta, Georgia, United States
Winship Cancer Institute
Atlanta, Georgia, United States
Start Date
December 21, 2021
Primary Completion Date
October 23, 2024
Completion Date
May 1, 2026
Last Updated
October 23, 2025
NCT07065630
NCT04988074
NCT07428330
NCT05639972
NCT07044635
NCT06147388
Lead Sponsor
Emory University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions